Graeme N Smith1, Jessica Pudwell1, Mark Walker2, Shi-Wu Wen2. 1. Department of Obstetrics & Gynaecology, Kingston General Hospital, Queen's University, Kingston ON; Department of Biomedical and Molecular Sciences, Kingston General Hospital, Queen's University, Kingston ON. 2. Department of Obstetrics and Gynecology, Ottawa Health Research Institute, University of Ottawa, Ottawa ON.
Abstract
OBJECTIVE: To calculate the cardiovascular disease (CVD) risk estimates for women following a pregnancy with or without preeclampsia. METHODS: We calculated 10-year, 30-year, and lifetime CVD risk estimates at one year postpartum for women recruited into the Pre-Eclampsia New Emerging Team's prospective cohort. RESULTS: Complete CVD risk screening data were obtained from 118 control women and 99 preeclamptic women. A total of 18.2% of preeclamptic women and 1.7% of control women had a high 10-year risk (OR 13.08; 95% CI 3.38 to 85.5), 31.3% of preeclamptic women and 5.1% of control women had a high 30-year risk (OR 8.43; 95% CI 3.48 to 23.23), and 41.4% of preeclamptic women and 17.8% of control women had a high lifetime risk for CVD (OR 3.25; 95% CI 1.76 to 6.11). CONCLUSIONS: The association of preeclampsia with the future development of CVD makes pregnancy an early window of opportunity for the preservation of health and prevention of CVD.
OBJECTIVE: To calculate the cardiovascular disease (CVD) risk estimates for women following a pregnancy with or without preeclampsia. METHODS: We calculated 10-year, 30-year, and lifetime CVD risk estimates at one year postpartum for women recruited into the Pre-Eclampsia New Emerging Team's prospective cohort. RESULTS: Complete CVD risk screening data were obtained from 118 control women and 99 preeclamptic women. A total of 18.2% of preeclamptic women and 1.7% of control women had a high 10-year risk (OR 13.08; 95% CI 3.38 to 85.5), 31.3% of preeclamptic women and 5.1% of control women had a high 30-year risk (OR 8.43; 95% CI 3.48 to 23.23), and 41.4% of preeclamptic women and 17.8% of control women had a high lifetime risk for CVD (OR 3.25; 95% CI 1.76 to 6.11). CONCLUSIONS: The association of preeclampsia with the future development of CVD makes pregnancy an early window of opportunity for the preservation of health and prevention of CVD.
Authors: Anne Marie Z Jukic; D Robert McConnaughey; Clarice R Weinberg; Allen J Wilcox; Donna D Baird Journal: Epidemiology Date: 2016-09 Impact factor: 4.822
Authors: H Stepan; S Kuse-Föhl; W Klockenbusch; W Rath; B Schauf; T Walther; D Schlembach Journal: Geburtshilfe Frauenheilkd Date: 2015-09 Impact factor: 2.915
Authors: L M O'Brien; A S Bullough; M C Chames; A V Shelgikar; R Armitage; C Guilleminualt; C E Sullivan; T R B Johnson; R D Chervin Journal: BJOG Date: 2014-05-30 Impact factor: 6.531
Authors: Ian K Everitt; Priya M Freaney; Michael C Wang; William A Grobman; Matthew J O'Brien; Lindsay R Pool; Sadiya S Khan Journal: Circ Cardiovasc Qual Outcomes Date: 2022-01-18
Authors: Wietske Hermes; Jouke T Tamsma; Diana C Grootendorst; Arie Franx; Joris van der Post; Maria G van Pampus; Kitty Wm Bloemenkamp; Martina Porath; Ben W Mol; Christianne J M de Groot Journal: BMC Pregnancy Childbirth Date: 2013-06-04 Impact factor: 3.007